Synergistic anti-tumoral effect of pacli
✍
Yona Kalechman; Dan L. Longo; Raphael Catane; Adi Shani; Michael Albeck; Benjami
📂
Article
📅
2000
🏛
John Wiley and Sons
🌐
French
⚖ 206 KB
Optimal doses of paclitaxel (Taxol) combined with the immunomodulator AS101, previously shown to have antitumoral effects, administered to B16 melanoma-bearing mice decreased tumor volume and resulted in over 60% cure. Paclitaxel؉AS101 directly inhibited the clonogenicity of B16 melanoma cells in a